CME GROUP ($CME) posted quarterly earnings results for Q1 2026 on Wednesday, April 22nd. The company reported earnings of $3.36 per share, missing estimates of $3.38 by $0.02. The company also reported revenue of $1,880,100,000, missing estimates of $1,898,319,038 by $-18,219,038.
You can see Quiver Quantitative's $CME stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CME GROUP Insider Trading Activity
CME GROUP insiders have traded $CME stock on the open market 15 times in the past 6 months. Of those trades, 4 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $CME stock by insiders over the last 6 months:
- TERRENCE A DUFFY (Chairman and CEO) has made 0 purchases and 2 sales selling 25,000 shares for an estimated $6,738,815.
- DEREK SAMMANN (Sr MD Gl Hd Commodities Mkts) has made 0 purchases and 2 sales selling 7,200 shares for an estimated $1,984,798.
- KEN VROMAN (Chief Transformation Officer) sold 5,160 shares for an estimated $1,594,440
- BRYAN T DURKIN sold 4,200 shares for an estimated $1,300,530
- JONATHAN L MARCUS (Sr MD General Counsel) sold 3,291 shares for an estimated $1,097,120
- WILLIAM R SHEPARD has made 4 purchases buying 1,732 shares for an estimated $510,109 and 0 sales.
- ELIZABETH A COOK sold 1,000 shares for an estimated $320,000
- HAROLD EUGENE JR. FORD sold 1,000 shares for an estimated $263,530
- DENNIS SUSKIND sold 748 shares for an estimated $224,400
- MARTIN J GEPSMAN sold 300 shares for an estimated $91,770
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CME GROUP Hedge Fund Activity
We have seen 829 institutional investors add shares of CME GROUP stock to their portfolio, and 711 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 7,716,211 shares (-75.0%) from their portfolio in Q4 2025, for an estimated $2,107,142,899
- VICTORY CAPITAL MANAGEMENT INC added 1,807,491 shares (+746.4%) to their portfolio in Q4 2025, for an estimated $493,589,642
- JPMORGAN CHASE & CO added 1,559,916 shares (+16.3%) to their portfolio in Q4 2025, for an estimated $425,981,861
- LONGVIEW PARTNERS (GUERNSEY) LTD added 1,386,768 shares (+inf%) to their portfolio in Q4 2025, for an estimated $378,698,605
- LONDON & CAPITAL ASSET MANAGEMENT LTD added 1,267,709 shares (+662.1%) to their portfolio in Q4 2025, for an estimated $346,185,973
- AMERIPRISE FINANCIAL INC removed 1,098,237 shares (-22.8%) from their portfolio in Q4 2025, for an estimated $299,906,559
- UBS GROUP AG removed 1,017,014 shares (-35.1%) from their portfolio in Q4 2025, for an estimated $277,726,183
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CME GROUP Congressional Stock Trading
Members of Congress have traded $CME stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CME stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/09.
- REPRESENTATIVE JULIE JOHNSON has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 12/18, 11/13.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CME GROUP Analyst Ratings
Wall Street analysts have issued reports on $CME in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Piper Sandler issued a "Overweight" rating on 11/13/2025
To track analyst ratings and price targets for CME GROUP, check out Quiver Quantitative's $CME forecast page.
CME GROUP Price Targets
Multiple analysts have issued price targets for $CME recently. We have seen 8 analysts offer price targets for $CME in the last 6 months, with a median target of $324.0.
Here are some recent targets:
- Patrick Moley from Piper Sandler set a target price of $329.0 on 04/15/2026
- Benjamin Budish from Barclays set a target price of $343.0 on 04/13/2026
- Michael Cyprys from Morgan Stanley set a target price of $362.0 on 04/10/2026
- Chris Allen from Keefe, Bruyette & Woods set a target price of $305.0 on 04/08/2026
- Bill Katz from TD Cowen set a target price of $328.0 on 02/05/2026
- Ashish Sabadra from RBC Capital set a target price of $302.0 on 02/05/2026
- Kenneth Worthington from JP Morgan set a target price of $266.0 on 02/05/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
